STALEVO

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, UK.

Active ingredients

The drug STALEVO contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 46627O600J - LEVODOPA
 

According to the current understanding, the symptoms of Parkinson’s disease are related to depletion of dopamine in the corpus striatum. Dopamine does not cross the blood-brain barrier. Levodopa, the precursor of dopamine, crosses the blood brain barrier and relieves the symptoms of the disease.

 
Read more about Levodopa
2
UNII MNX7R8C5VO - CARBIDOPA
 

Carbidopa is a peripheral aromatic amino acid decarboxylase inhibitor. It prevents metabolism of levodopa to dopamine in the peripheral circulation, ensuring that a higher proportion of the dose reaches the brain, where dopamine exerts its therapeutic effects. A lower dose of levodopa can be used when it is coadministered with carbidopa, reducing the incidence and severity of peripheral side effects.

 
Read more about Carbidopa
3
UNII 4975G9NM6T - ENTACAPONE
 

Entacapone belongs to a new therapeutic class, catechol-O-methyl transferase (COMT) inhibitors. It is a reversible, specific, and mainly peripherally acting COMT inhibitor designed for concomitant administration with levodopa preparations. Entacapone prolongs the clinical response to levodopa.

 
Read more about Entacapone

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 STALEVO Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BA Dopa and dopa derivatives
Discover more medicines within N04BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 8797B, 8798C, 8799D, 9292C, 9344T, 9345W
BR Câmara de Regulação do Mercado de Medicamentos 511521010072617, 511521010072717, 511521010072817
CA Health Products and Food Branch 02305933, 02305941, 02305968, 02337827, 02337835
DE Bundesinstitut für Arzneimittel und Medizinprodukte 00003056, 00159947, 00206380, 00206411, 00209697, 00209705, 00215410, 00215427, 00325328, 00363441, 00363470, 00996175, 00996181, 01043514, 01055569, 01433126, 01437791, 01682668, 01682728, 01682757, 01897274, 02031654, 02031660, 02034279, 02208785, 02208839, 02208897, 02731222, 02733296, 02847479, 03070337, 03116602, 03445990, 03446239, 03450838, 04551062, 04551079, 04551116, 04866920, 04866995, 04867055, 04871619, 04871708, 06140067, 06140073, 06309626, 06407808, 06468974, 06492091, 06492116, 06888943, 06907310, 06908261, 06908284, 07238733, 07238756, 07404841, 09339059, 09339065, 09481946, 09485743, 09485766, 09508680, 09616642, 09632776, 09637354, 09775783, 09938073, 10000254, 10000260, 10000277, 10000283, 10070823, 16124017, 16124023, 16124046, 16802210, 17526491, 17927020, 17927037
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 26.082-12-04, 26.083-12-04, 26.084-12-04, 29299-07-10, 29591-01-11, 30305-10-12
EE Ravimiamet 1172797, 1172809, 1172810, 1172821, 1172832, 1172843, 1172854, 1172865, 1172876, 1172887, 1172898, 1172900, 1265150, 1265161, 1265172, 1367973, 1367984, 1367995, 1368008, 1368019, 1368020, 1368042, 1368053, 1472206, 1472217, 1472228, 1472240, 1472251, 1472262, 1472273, 1472284, 1472295, 1472307, 1538568, 1538579, 1538580, 1538603, 1538614, 1843635
ES Centro de información online de medicamentos de la AEMPS 03260003, 03260007, 03260011, 03260021, 03260026, 03260031
FI Lääkealan turvallisuus- ja kehittämiskeskus 015605, 015652, 015655, 015663, 015707, 015718, 032112, 032124, 032146, 032157, 140974, 491775
FR Base de données publique des médicaments 61186758, 62892111, 65247735, 65927172, 66851724, 68232927, 69044807
GB Medicines & Healthcare Products Regulatory Agency 136449, 136450, 139545, 139555, 154404, 154405, 154409, 154410, 162489, 162491, 162493, 181928, 181930, 181934, 197016, 197017, 368960, 368965, 368970, 368973, 368975, 375345, 375348, 375351, 377034, 377303, 381680, 391758, 52989, 52992, 52997, 52999, 53023, 53028
HK Department of Health Drug Office 52081, 59640, 59652, 60086, 60104, 60105
IE Health Products Regulatory Authority 13206, 13207, 13208, 45401, 45433, 45482, 45730, 45762, 45782, 45794, 61530, 62440, 62441, 62442, 62443, 62464, 62475, 62501, 62505, 62534, 62580, 62622, 62654, 62680, 70415, 71596, 72581, 73147, 74802
IL מִשְׂרַד הַבְּרִיאוּת 4844, 4845, 4846, 6454, 6457, 6458
IT Agenzia del Farmaco 036825038, 036825077, 036825115, 036825216, 036825242, 036825255
JP 医薬品医療機器総合機構 1169102F1027, 1169102F2023
LT Valstybinė vaistų kontrolės tarnyba 1004403, 1004404, 1004405, 1004912, 1005015, 1005016, 1005017, 1005018, 1005544, 1005545, 1005546, 1005547, 1030854, 1030855, 1030856, 1030857, 1030858, 1030859, 1030860, 1030861, 1030862, 1030863, 1030864, 1030865, 1032125, 1032126, 1032127, 1037732, 1037735, 1037736, 1037737, 1037740, 1037741, 1063134, 1063135, 1063136, 1063137, 1063138
MX Comisión Federal para la Protección contra Riesgos Sanitarios 499M2004
NL Z-Index G-Standaard, PRK 119938, 119946, 119954, 86703, 89680, 89699
NZ Medicines and Medical Devices Safety Authority 11072, 11073, 11074, 13337, 13825, 13826
PL Rejestru Produktów Leczniczych 100129802, 100129819, 100129825, 100196425, 100209955, 100209961, 100261915
SG Health Sciences Authority 13141P, 13142P, 13143P, 13566P
US FDA, National Drug Code 0078-0407, 0078-0408, 0078-0409, 0078-0527, 0078-0544, 0078-0545, 52427-805, 52427-809, 52427-816, 52427-827, 52427-834, 52427-842
ZA Health Products Regulatory Authority 38/5.4.1/0138

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.